Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 102 | 2 | 101 | +1 |
| Shares | 28.9M | 3.33M | 29.1M | +3.62M (+14.2%) |
| Value | $402.0M | $46.5M | $332.0M | −$23.5M (−6.6%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 3,334,905 | $38.0M | 0.04% |
| Great Point Partners LLC | 480,000 | $5.47M | 1.29% |
| Granahan Investment Management Inc | 405,834 | $4.62M | 0.09% |
| Point72 Asset Management, L.P. | 375,100 | $4.27M | 0.02% |
| Woodline Partners LP | 234,357 | $2.67M | 0.04% |
| Rubric Capital Management LP | 153,618 | $1.75M | 0.10% |
| M&G Investment Management Ltd | 142,527 | $1.57M | 0.01% |
| Ikarian Capital, LLC | 59,422 | $677.0K | 0.16% |
| ExodusPoint Capital Management, LP | 39,987 | $455.0K | 0.01% |
| UBS Asset Management Americas Inc | 35,490 | $404.2K | 0.00% |
| Qube Research & Technologies Ltd | 32,141 | $366.0K | 0.00% |
| HRT Financial LP | 18,869 | $214.0K | 0.00% |
| SG Americas Securities, LLC | 18,551 | $211.0K | 0.00% |
| Jane Street Group, LLC | 17,921 | $204.0K | 0.00% |
| Man Group plc | 15,400 | $175.0K | 0.00% |
| Northeast Financial Consultants Inc | 11,440 | $130.0K | 0.01% |
| HSBC Holdings PLC | 10,040 | $115.0K | 0.00% |
| Metropolitan Life Insurance Co | 4,573 | $52.1K | 0.00% |
| Point72 Hong Kong Ltd | 1,813 | $21.0K | 0.00% |
| Signaturefd, LLC | 66 | $1.00K | 0.00% |
Sold out (19)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Janus Henderson Group PLC | 1,096,252 | $15.3M |
| Logos Global Management LP | 800,000 | $11.1M |
| Balyasny Asset Management LLC | 400,296 | $5.58M |
| Two Sigma Advisers, LP | 72,300 | $1.01M |
| Two Sigma Investments, LP | 49,232 | $686.0K |
| Jacobs Levy Equity Management, Inc | 47,178 | $657.0K |
| Cetera Advisor Networks LLC | 43,632 | $608.0K |
| AlphaCentric Advisors LLC | 32,500 | $453.0K |
| Squarepoint Ops LLC | 28,744 | $400.0K |
| Cerity Partners LLC | 25,000 | $348.0K |
| Parallax Volatility Advisers, L.P. | 16,586 | $231.0K |
| Price T Rowe Associates Inc | 13,231 | $184.0K |
| Cowen and Company, LLC | 10,000 | $139.0K |
| SG3 Management, LLC | 8,500 | $118.0K |
| Quantbot Technologies LP | 2,754 | $38.0K |
| Advisory Services Network, LLC | 701 | $10.0K |
| Mirae Asset Global Investments Co., Ltd. | 526 | $7.00K |
| Beck Bode, LLC | 300 | $4.00K |
| State of Wyoming | 235 | $3.00K |
Not filed for Q3 2021 yet (2)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 3,334,905 | $46.5M |
| CWM, LLC | 55 | $1.00K |